| Cover | Jul. 09, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jul. 09, 2024 |
| Entity File Number | 001-41615 |
| Entity Registrant Name | MANGOCEUTICALS, INC. |
| Entity Central Index Key | 0001938046 |
| Entity Tax Identification Number | 87-3841292 |
| Entity Incorporation, State or Country Code | TX |
| Entity Address, Address Line One | 15110 N. Dallas Parkway |
| Entity Address, Address Line Two | Suite 600 |
| Entity Address, City or Town | Dallas |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 75248 |
| City Area Code | (214) |
| Local Phone Number | 242-9619 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 Par Value Per Share |
| Trading Symbol | MGRX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
